Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New program aims to help MSA patients and families cope

NCT ID NCT05819957

First seen May 10, 2026 · Last updated Jun 19, 2026 · Updated 9 times

Summary

This study tested whether a 12-month therapeutic education program is feasible for people with multiple system atrophy (MSA) and their caregivers. The program includes in-person visits and online activities to help understand symptoms and adapt to daily life. Fifteen patient-caregiver pairs participated, and the main goal was to see if at least 80% would stay in the program for 6 and 12 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SYSTEM ATROPHY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • CHU Toulouse

    Toulouse, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

therapeutic education program

What this could lead to

If successful, this program could provide a structured way for MSA patients and caregivers to better understand and cope with the disease, improving quality of life.

What could go wrong

This is a very small feasibility study with only 15 participants, so results may not apply to everyone. The program requires internet access and regular visits, which may be challenging for some.

Conditions

The condition(s) this trial relates to.

multiple system atrophy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.